Methods: Sixteen patients with platinum-resistant squamous cell carcinoma were treated with CPT-11 as second-line therapy.

However, long-term survival in CCC patients treated with CPT-P as first-line chemotherapy remains to be determined.

Material and methods: We performed a retrospective review of 31 patients with CCC who were treated with CPT-P between 1996 and 2004.